How David Baker taught computers to build life from scratch using custom proteins

How David Baker taught computers to build life from scratch using custom proteins
Image: Intellect (generated)

In short: For decades, scientists could only study the proteins nature provided. David Baker changed that by creating Rosetta, a computational platform that designs entirely new proteins with bespoke functions. His work, which earned him the 2024 Nobel Prize, has unlocked a new era of synthetic biology, medicine, and industrial innovation.

Born in Seattle in 1962, David Baker initially pursued philosophy and social science at Harvard before pivoting to biology. After earning his Ph.D. from the University of California, Berkeley, in 1989, he moved to the University of Washington in 1993. There, he began investigating the complex rules governing how amino acid sequences fold into the specific three-dimensional shapes that dictate protein function.

Baker’s breakthrough arrived through the development of Rosetta, a software platform rooted in a Monte Carlo sampling algorithm. While traditional methods like mass spectrometry provided data, Rosetta allowed researchers to simulate protein folding. By 1998, the software proved its predictive power in the Critical Assessment of protein Structure Prediction competition. Baker then inverted the process: instead of predicting a shape from a sequence, he used the software to determine the sequence required to build a specific, desired shape.

The turning point occurred in 2003 with the creation of Top7, the first protein designed and produced from scratch. Composed of 93 amino acids, Top7 demonstrated that scientists could achieve atomic-level accuracy in protein engineering. This capability has since expanded into therapeutic applications, including the development of mini-proteins designed to inhibit viruses like SARS-CoV-2. Today, Baker leads the Institute for Protein Design, where his team continues to integrate machine learning to solve urgent challenges in sustainability and medicine.

Baker’s influence extends far beyond the laboratory. He has published over 650 scientific papers, holds more than 100 patents, and has co-founded 21 biotechnology companies. His contributions have been recognized with numerous accolades, including the 2021 Breakthrough Prize in Life Sciences and the 2024 Nobel Prize in Chemistry, which he shared with Demis Hassabis and John M. Jumper. By bridging the gap between computational modeling and experimental biochemistry, Baker has transformed proteins from biological mysteries into programmable tools.

Opens the Intellect+ feed with this card first. Swipe up for the next one.

Sources

To cite this card, link to https://intellectplus.co.uk/app/science-david-baker-biochemist.

How we source, check and correct cards: Editorial standards.

General information, not professional advice. Spotted an error? Flag the card or see corrections and complaints.

Intellect Plus is a visual educational discovery platform for exploring fascinating facts and ideas. Brain Food, Not Brain Rot. What is Intellect Plus?

Related

Finding something worth knowing…